Belite Bio BLTE
NASDAQ BLTE
$187.80 +16.71 (+9.77%)
As of: Sep 4, 2026 · 1:33 PM EDT

Belite Bio (BLTE) EPS (Basic) (2022 - 2026)

Belite Bio (BLTE) posted quarterly EPS (Basic) of -$0.0 for Q1 2026, down 7129901.33% year-over-year from N/an in Q1 2025, and down 4791265.71% quarter-over-quarter from $0.0 in Q4 2025.

Analysis

Belite Bio (BLTE) EPS (Basic) (2022 - 2026) Analysis & Trends

Belite Bio's EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.0 for Q1 2026.

  • In Q1 2026, EPS (Basic) fell 7129901.33% year-over-year to -$0.0; the TTM figure through Mar 2026 stood at $0.0 (up 6900341.92% YoY), while the FY2025 annual figure was $0.0, up 78.25% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.0, down from $0.0 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.0 in Q4 2025, with the low at -$0.0 in Q1 2026.
  • The 5-year median for EPS (Basic) is $0.0 (2023), against an average of -$0.0.
  • The sharpest annual moves came in 2025 and 2026: EPS (Basic) jumped 315.04% in 2025, then sank 7129901.33% in 2026.
  • Belite Bio's EPS (Basic) stood at $0.0 in 2022, then plunged by 30.45% to $0.0 in 2023, then rose by 11.47% to $0.0 in 2024, then surged by 99.18% to $0.0 in 2025, then sank by 4791265.71% to -$0.0 in 2026.
  • Business Quant data shows BLTE's EPS (Basic) at -$0.0 in Q1 2026, $0.0 in Q4 2025, and $0.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 12.62
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn 7.70
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.08 Bn 44.08 Bn - -3.06
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 2.12
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 1.23
8 Royalty Pharma 28.44 Bn 27.60 Bn - 0.18
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -0.06
10 Belite Bio 6.31 Bn 6.31 Bn - -0.85
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.85
Mar 31, 2026 -0.80
Dec 31, 2025 0.00
Sep 30, 2025 -0.71
Jun 30, 2025 -0.53
Mar 31, 2025 -0.47
Dec 31, 2024 0.00
Sep 30, 2024 -0.33
Jun 30, 2024 -0.36
Mar 31, 2024 -0.30
Dec 31, 2023 -0.26
Sep 30, 2023 -0.55
Jun 30, 2023 0.00
Mar 31, 2023 -0.35
Dec 31, 2022 -0.34
Jun 30, 2022 -0.25